Journal for ImmunoTherapy of Cancer

Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer
Stephanie O. Dudzinski, Brent D. Cameron, Jian Wang, Jeffrey C. Rathmell, Todd D. Giorgio, Austin N. Kirschner

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 218; DOI: 10.1186/s40425-019-0704-z
Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer
Shahnawaz Imam, Pervaiz Dar, Rodis Paparodis, Khalil Almotah, Ahmed Al-Khudhair, Syed Abdul-Moiz Hasan, Nancy Salim, Juan Carlos Jaume

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 3; DOI: 10.1186/s40425-018-0483-y
PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8⁺ T lymphocytes
Jesús Ogando, María Eugenia Sáez, Javier Santos, Cristina Nuevo-Tapioles, Marta Gut, Anna Esteve-Codina, Simon Heath, Antonio González-Pérez, José M. Cuezva, Rosa Ana Lacalle, Santos Mañes

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 151; DOI: 10.1186/s40425-019-0628-7
Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy
Xiang-Min Tong, Liang Feng, Sreedhar Reddy Suthe, Tian-Hao Weng, Chen-Yu Hu, Yi-Zhi Liu, Zhi-Gang Wu, Ming-Hai Wang, Hang-Ping Yao

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 250; DOI: 10.1186/s40425-019-0732-8
Cancer-cell-secreted CXCL11 promoted CD8⁺ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
Qun Gao, Shumin Wang, Xinfeng Chen, Shaoyan Cheng, Zhen Zhang, Feng Li, Lan Huang, Yang Yang, Bin Zhou, Dongli Yue, Dan Wang, Ling Cao, Nomathamsanqa Resegofetse Maimela, Bin Zhang, Jane Yu, Liping Wang, Yi Zhang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 42; DOI: 10.1186/s40425-019-0511-6
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
Bridget P. Keenan, Lawrence Fong, Robin K. Kelley

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 267; DOI: 10.1186/s40425-019-0749-z
miR-34a as hub of T cell regulation networks
Martin Hart, Barbara Walch-Rückheim, Lena Krammes, Tim Kehl, Stefanie Rheinheimer, Tanja Tänzer, Birgit Glombitza, Martina Sester, Hans-Peter Lenhof, Andreas Keller, Eckart Meese

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 187; DOI: 10.1186/s40425-019-0670-5
Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
Yinghong Zhai, Xiaofei Ye, Fangyuan Hu, Jinfang Xu, Xiaojing Guo, Yonglong Zhuang, Jia He

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 286; DOI: 10.1186/s40425-019-0754-2
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
A. Pavan, I. Attili, G. Pasello, V. Guarneri, P. F. Conte, L. Bonanno

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 205; DOI: 10.1186/s40425-019-0690-1
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Jonathan D. Schoenfeld, Mizuki Nishino, Mariano Severgnini, Michael Manos, Raymond H. Mak, F. Stephen Hodi

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 112; DOI: 10.1186/s40425-019-0583-3

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages